首页> 外国专利> METHOD OF MONITORING FIBROUS PROCESS IN LIVER OF PATIENTS WITH CHRONIC HEPATITIS C

METHOD OF MONITORING FIBROUS PROCESS IN LIVER OF PATIENTS WITH CHRONIC HEPATITIS C

机译:慢性丙型肝炎患者肝纤维过程监测方法

摘要

FIELD: medicine.SUBSTANCE: invention relates to field of medicine, in particular hepatology and infectious diseases, and can be used for determination of stage of fibrous process in monitoring of patients with chronic hepatitis C. To realise method levels of blood serum cytokins are determined in patients with chronic hepatitis C with diagnosed by means of biopsy or other non-invasive method stage of fibrous process 2 times a year, with further calculation of cytokine profile integral index (CPII) on their basis, at initial stage F0 growth of CPII higher than -8 testifies to debut of fibrous changes in liver (transition to stage F1), at initial stage F1, drop of CPII below -10 testifies to transition to stage F2, at initial stage F2 growth of CPII higher than -3 testifies to transition of fibrosis to stage F3, at initial stage F3 drop of CPII below -3 testifies to development of cirrhosis.EFFECT: determination of stage of fibrous process in monitoring of patients with chronic hepatitis C.3 ex, 1 tbl, 5 dwg
机译:技术领域本发明涉及医学领域,特别是肝病学和感染性疾病,可用于确定监测慢性丙型肝炎患者的纤维化进程的阶段。实现确定血清细胞因子水平的方法通过活检或其他非侵入性方法在纤维化过程阶段诊断为慢性丙型肝炎的患者,每年两次,并根据其基础进一步计算细胞因子谱积分指数(CPII),在初始阶段CPII的F0增高高于-8的值表明肝脏纤维性改变首次出现(过渡至F1期),在初始阶段F1,CPII低于-10则表明过渡至F2期,在初始的F2阶段CPII高于-3的生长表明过渡纤维化进入F3期,在F3初期,CPII降至-3以下证明肝硬化的发展。效果:确定纤维化过程的阶段以监测慢性肝炎患者C.3 ex,1 tbl,5 dwg

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号